-
Overview
Date & Location
12/9/2020 – 12/9/2021, 12:00 AM CST Online
Overview
This podcast discusses the latest updates on vaccine trials to include the development processes used for the leading vaccine candidates. Strategies for the development of these vaccines is discussed and the timeline for vaccine distribution is also outlined. Finally, Dr. Taylor discusses what she believes our world will look like once vaccines are available.
Target Audience
This educational activity is designed to meet the educational goals of physicians and other healthcare professionals specializing in infectious diseases, family and community medicine, internal medicine, emergency medicine, and all those involved with the management of patients with coronavirus.
Learning Objectives for the Episode 4
- Describe the vaccine development processes used for leading COVID-19 vaccine candidates.
- Compare and contrast the leading COVID-19 vaccine candidates.
- Outline the timeline for COVID-19 vaccine distribution.
- Describe what a post-vaccine world will look like in the short-term and in the long-term.
Program Registration Information
Registration Fees - $0.00
Continuing Medical Education Education Credit - Accreditation and Designation Statement
The Joe R. and Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Long School of Medicine designates this enduring material for a maximum of .50 AMA PRA Category 1 Creditsâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû evaluation.
Release date: 12/9/2020 Credits expire: 12/9/2021
-
Faculty
Jan E. Patterson, MD, MS, MACP
FIDSA, FSHEA, CHCP
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality & Lifelong Learning
Joe R. and Teresa Lozano Long School of Medicine
¸£Àû͵ÅÄ91 ÉîÒ¹¸£ÀûDr. Patterson is a Professor of Medicine/Infectious Diseases and Associate Dean for Quality & Lifelong Learning at The Joe R. and Teresa Lozano Long School of Medicine, ¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû. She is clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society for Healthcare Epidemiology of America. She is a longtime infectious diseases consultant to Southwest Texas Regional Advisory Council (STRAC) and has also served on CDC¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû Healthcare Infection Practices Advisory Committee and has been a consultant to San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and is currently a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies as outlined above and is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at ¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû and University Hospital.
Barbara S. Taylor, MD, MS
Associate Professor of Infectious Diseases
Assistant Dean for the MD/MPH Program
Joe R. and Teresa Lozano Long School of Medicine
¸£Àû͵ÅÄ91 ÉîÒ¹¸£ÀûDr. Barbara Taylor is an Associate Professor of Infectious Diseases and the Assistant Dean for the MD/MPH Program at ¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû with co-appointments at the ¸£Àû͵ÅÄ91 ÉîÒ¹¸£Àû School of Public Health and the Columbia University College of Physicians and Surgeons. She has disclosed that she is a principal investigator for the COVID-19 Prevention Network.
Relevant Financial Disclosures
Dr. Jan Patterson has disclosed that she is a NIH ACTT co-investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial.
Dr. Barbara Taylor has disclosed that she is a principal investigator for the COVID-19 Prevention Network.
